Infinity Pharmaceuticals Stock Today
| INFIQ Stock | 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Infinity Pharmaceuticals is selling at 1.0E-4 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. Infinity Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Infinity Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of July 2000 | Category Healthcare | Classification Health Care |
Infinity Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 90.76 M outstanding shares of which 2.21 M shares are currently shorted by private and institutional investors with about 0.31 days to cover all short positions. More on Infinity Pharmaceuticals
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Infinity Stock Highlights
| Senior CEO | Seth JD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infinity Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Infinity Pharmaceuticals' financial leverage. It provides some insight into what part of Infinity Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infinity Pharmaceuticals (INFIQ) is traded on NASDAQ Exchange in USA and employs 30 people. Infinity Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.08 K. Infinity Pharmaceuticals classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 90.76 M outstanding shares of which 2.21 M shares are currently shorted by private and institutional investors with about 0.31 days to cover all short positions.
Infinity Pharmaceuticals generates negative cash flow from operations
Check Infinity Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationInfinity Pharmaceuticals has a total of 90.76 Million outstanding shares. Roughly 97.32 (percent) of Infinity Pharmaceuticals outstanding shares are held by general public with 2.68 % owned by insiders and only 0.0 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Infinity Ownership Details
Infinity Stock Against Markets
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.